Lifetime Cumulative Effect of Reproductive Factors on Stroke and Its Subtypes in Postmenopausal Chinese: A Prospective Cohort Study
Citation Manager Formats
Make Comment
See Comments

Abstract
Background Multiple reproductive factors are associated with stroke. Little is known about the cumulative effects of reproductive factors during a reproductive life course on stroke and its subtypes, especially among female Chinese.
Objective To assess the associations of lifetime cumulative estrogen exposure due to reproductive factors with stroke and its etiological subtypes among postmenopausal Chinese .
Methods From the China Kadoorie Biobank (CKB) study, postmenopausal females without prior stroke at baseline (2004-2008) were selected. Lifetime cumulative estrogen exposure due to reproductive factors was assessed using three composite indicators: reproductive lifespan (RLS), endogenous estrogen exposure (EEE), and total estrogen exposure (TEE). Stroke and its subtypes, ischemic stroke (IS), intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), were identified via linkage to a disease registry system and health insurance data during follow-up (2004-2015). Multivariable-adjusted Cox proportional hazards regression models were applied to estimate the adjusted hazard ratio (aHR) and 95% confidence intervals (CI) for the risk of stroke by quartiles of RLS, EEE, and TEE respectively.
Results A total of 122,939 postmenopausal participants aged 40 to 79 years without prior stroke at baseline were included. During a median follow-up period of 8.9 years, 15,139 new-onset stroke cases were identified, including 12,853 IS, 2,580 ICH, and 269 SAH cases. Compared with the lowest quartile (Q1) of RLS, the highest quartile (Q4) had a lower risk of total stroke (aHR: 0.95, 95% CI: 0.92-0.98), IS (aHR: 0.95, 95% CI: 0.92-0.98), and ICH (aHR: 0.87, 95% CI: 0.81-0.94). Both EEE and TEE displayed a graded association with the subsequent descending risk of total stroke (aHR for Q4 vs Q1: EEE: 0.85, 95% CI: 0.82-0.89; TEE: 0.87, 95% CI: 0.84-0.90), IS (aHR for Q4 vs Q1: EEE: 0.86, 95% CI: 0.83-0.90; TEE: 0.86, 95% CI: 0.83-0.89), and ICH (EEE: 0.73, 95% CI: 0.65-0.81; TEE: 0.83,95% CI: 0.76-0.91), with a P-trend<0.001 for all of these associations.
Conclusions Patients’ cumulative estrogen exposure due to reproductive factors could potentially be a valuable indicator for risk stratification of stroke events following menopause.
- Received June 15, 2022.
- Accepted in final form December 12, 2022.
- Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
- No related articles found.